Top compounds associated with response to MYB


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.077 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC 0.23 7e-06
mRNA tivozanib CTRPv2 pan-cancer AAC 0.18 3e-05
mRNA tosedostat CTRPv2 pan-cancer AAC 0.02 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 8e-06
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.094 0.05
mRNA triptolide CTRPv2 pan-cancer AAC 0.024 0.6
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.27 2e-09
Download CSV